Global Medical REIT Inc. (GMRE)
NYSE: GMRE · Real-Time Price · USD
6.23
-0.08 (-1.27%)
At close: Jun 5, 2025, 4:00 PM
6.23
0.00 (0.00%)
After-hours: Jun 5, 2025, 4:10 PM EDT

Global Medical REIT Stock Forecast

Stock Price Forecast

According to 2 professional analysts, the 12-month price target for Global Medical REIT stock ranges from a low of $9.00 to a high of $11.75. The average analyst price target of $10.38 forecasts a 66.61% increase in the stock price over the next year.

Price Target: $10.38 (+66.61%)
Analyst Consensus: Buy
Target Low Average Median High
Price $9.00 $10.38 $11.75 $11.75
Change +44.46% +66.61% +88.60% +88.60%

Analyst Ratings

The average analyst rating for Global Medical REIT stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '25Feb '25Mar '25Apr '25May '25Jun '25
Strong Buy 222221
Buy 000000
Hold 001122
Sell 000000
Strong Sell 000000
Total 223343

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Baird
Baird
Hold
Maintains
$10$9
Hold Maintains $10$9 +44.46% May 8, 2025
Citizens Capital Markets
Citizens Capital Markets
Hold
Reiterates
n/a
Hold Reiterates n/a n/a Mar 12, 2025
Berenberg
Berenberg
Strong Buy
Initiates
$12
Strong Buy Initiates $12 +88.60% Oct 18, 2024
B. Riley Securities
B. Riley Securities
Strong Buy
Maintains
$11$10
Strong Buy Maintains $11$10 +60.51% May 13, 2024
B. Riley Securities
B. Riley Securities
Strong Buy
Maintains
$12$11
Strong Buy Maintains $12$11 +76.57% May 8, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
145.38M
from 138.76M
Increased by 4.77%
Revenue Next Year
151.59M
from 145.38M
Increased by 4.27%
EPS This Year
0.07
from 0.01
Increased by 480.54%
EPS Next Year
0.09
from 0.07
Increased by 21.43%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
93.73M115.94M137.28M141.05M138.76M145.38M151.59M152.80M
Revenue Growth
32.53%23.69%18.41%2.74%-1.62%4.77%4.27%0.80%
EPS
-0.170.190.200.230.010.070.090.10
EPS Growth
--4.57%10.89%-94.55%480.54%21.43%17.65%
Forward PE
-----87.2571.8661.08
No. Analysts
-----874
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 2025202620272028
High 151.8M 163.8M 159.6M
Avg 145.4M 151.6M 152.8M
Low 136.9M 141.6M 144.7M

Revenue Growth

Revenue Growth 2025202620272028
High
9.4%
12.7%
5.3%
Avg
4.8%
4.3%
0.8%
Low
-1.4%
-2.6%
-4.6%

EPS Forecast

EPS 202520262027
High 0.07 0.12 0.11
Avg 0.07 0.09 0.10
Low 0.07 0.06 0.10

EPS Growth

EPS Growth 202520262027
High
497.6%
61.8%
21.1%
Avg
480.5%
21.4%
17.6%
Low
457.8%
-17.6%
13.0%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.